Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Disorders of the Male Reproductive System

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...

Cancer Prevention

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...

Nursing Assessment of the Genitourinary System I: Health History

Nursing Assessment of the Genitourinary System I: Health History

The genitourinary system is critical to maintaining fluid balance, waste elimination, and reproductive function. Nurses play a vital role in assessing this system, beginning with a thorough health history. This process involves gathering patient information, identifying risk factors, and recognizing symptoms of genitourinary disorders. Early detection is vital for timely interventions and management.1. Gathering Patient InformationA complete health history includes the patient’s personal,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Water Vapor Therapy for the Management of Prostate Cancer: The VAPOR 2 Study Initial Results of Ablative Efficacy and Toxicity.

The Journal of urology·2026

Same author

Development and psychometric evaluation of a patient-reported symptom index for patients with non-muscle invasive bladder cancer: the NMIBC-SI.

Journal of patient-reported outcomes·2025

Same author

Synergistic RAS-MAPK and AKT Activation in MYC-Driven Tumors via Adjacent PVT1 Rearrangements.

bioRxiv : the preprint server for biology·2025

Same author

Racial Disparities in Clinical Trial Enrollment Among Patients Diagnosed With Prostate Cancer: A Population-Based Cohort of Oncology Practices.

Advances in urology·2024

Same author

Diagnostic yield of upper tract imaging performed for hematuria screening: Results from a national, privately-insured cohort.

Urologic oncology·2024

Same author

Identifying the best candidate for focal therapy: a comprehensive review.

Prostate cancer and prostatic diseases·2024

Search research articles

Related Experiment Video

Updated: Jun 8, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

Prostate cancer screening: issues and controversies.

Matthew O'Shaughnessy¹, Badrinath Konety, Christopher Warlick

¹Department of Urologic Surgery, University of Minnesota, USA.

Minnesota Medicine

|September 25, 2010

Summary

Prostate cancer screening using prostate-specific antigen (PSA) tests is controversial due to inconsistent accuracy and debates on necessary treatment. Individual patient-physician decisions guide current screening practices.

More Related Videos

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance

Published on: June 6, 2025

Related Experiment Videos

Last Updated: Jun 8, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance

Published on: June 6, 2025

Area of Science:

Urology
Oncology
Medical Screening

Background:

Prostate cancer is a significant cause of male mortality.
Early detection is believed to improve outcomes, driving interest in screening.
Prostate-specific antigen (PSA) blood testing has been the primary screening method since the late 1980s.

Purpose of the Study:

To review current understanding and research on PSA testing for prostate cancer.
To highlight key findings related to PSA screening efficacy and prostate cancer treatment necessity.
To discuss potential future shifts in prostate cancer screening and management strategies.

Main Methods:

Review of existing literature and research findings on PSA testing.
Analysis of controversies surrounding PSA test accuracy and interpretation.
Examination of evidence regarding the necessity of definitive prostate cancer treatment.

Main Results:

PSA levels can be elevated without cancer and normal despite cancer presence.
Evidence is conflicting regarding the universal indication for definitive prostate cancer treatment.
National organizations have issued varied guidelines for PSA screening.

Conclusions:

The efficacy of PSA screening and the necessity of prostate cancer treatment remain debated.
Screening decisions are individualized, relying on patient and physician judgment.
Future changes in screening and treatment protocols are anticipated.